AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
203.10
+2.22 (1.11%)
Feb 21, 2025, 3:22 PM EST - Market open

AbbVie Revenue

In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth. AbbVie had revenue of $15.10B in the quarter ending December 31, 2024, with 5.60% growth.

Revenue (ttm)
$56.33B
Revenue Growth
+3.71%
P/S Ratio
6.31
Revenue / Employee
$1,024,255
Employees
55,000
Market Cap
358.68B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202456.33B2.02B3.71%
Dec 31, 202354.32B-3.74B-6.44%
Dec 31, 202258.05B1.86B3.30%
Dec 31, 202156.20B10.39B22.69%
Dec 31, 202045.80B12.54B37.69%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Abbott Laboratories 41.95B
Revenue Rankings